Prevalence of Post-transplant Diabetes Mellitus (PTDM) and Cardiovascular (CV) Risk Factors After Lung Transplantation

Lung transplantation is a life-prolonging treatment for end-stage pulmonary diseases. The prevalence of metabolic derangements and cardiovascular (CV) risk factors has not been well-characterized in this population, although CV disease is known to be a significant cause of mortality after lung transplantation. The purpose of this retrospective study was to determine the prevalence of metabolic derangements, including post-transplant diabetes mellitus (PTDM) and dyslipidemia in a cohort of lung transplant recipients at our centre.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Source Type: research